Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07556406 · ClinicalTrials.gov registry record
Central micrOperimetry and Radial OCT Evaluation in Geographic Atrophy (CORE-GA): a Prospective Pilot Study
A clinical trial, sponsored by University of California, San Francisco.
- Recruiting
- Registry status
- 80
- Enrollment target
NCT07556406: Recruiting study, sponsored by University of California, San Francisco.
NCT07556406 is a clinical trial that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 80 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07556406 is actively recruiting participants, sponsored by University of California, San Francisco.
- RECRUITING
- Registry status
- 80 participants
- Enrollment target
Study Summary
This study is being conducted to assess two imaging methods-central microperimetry and radial OCT (Optical Coherence Tomography)-in patients with Geographic Atrophy (GA) or those who are at risk of developing this condition. The study team is trying to determine whether these methods can provide more accurate measurements of GA progression toward the foveal center, the central part of the retina responsible for your sharpest, most detailed vision.
Primary Outcome
Quantify the progression rate of geographic atrophy toward the foveal center over time
Interventions
- DIAGNOSTIC_TEST Optical coherence tomography
- DIAGNOSTIC_TEST Microperimetry
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2025-06-11 |
| Est. Completion | 2027-06-11 |
What NCT07556406 shows while recruiting
NCT07556406 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 80 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Optical coherence tomography is the first listed.
NCT07556406 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07556406 about?
NCT07556406 is a clinical study titled "Central micrOperimetry and Radial OCT Evaluation in Geographic Atrophy (CORE-GA): a Prospective Pilot Study". This study is being conducted to assess two imaging methods-central microperimetry and radial OCT (Optical Coherence Tomography)-in patients with Geographic Atrophy (GA) or those who are at risk of developing this condition. The study team is trying to determine whether these methods can provide mor...
What is the current status of trial NCT07556406?
This trial is currently recruiting. The enrollment target is 80 participants. The study started on 2025-06-11. Estimated completion is 2027-06-11.
What interventions are being tested in trial NCT07556406?
The interventions under investigation include: Optical coherence tomography (DIAGNOSTIC_TEST), Microperimetry (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT07556406?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI